FR2018070A1 - - Google Patents

Info

Publication number
FR2018070A1
FR2018070A1 FR6931175A FR6931175A FR2018070A1 FR 2018070 A1 FR2018070 A1 FR 2018070A1 FR 6931175 A FR6931175 A FR 6931175A FR 6931175 A FR6931175 A FR 6931175A FR 2018070 A1 FR2018070 A1 FR 2018070A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR6931175A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19681793422 external-priority patent/DE1793422C3/de
Application filed by Schering AG filed Critical Schering AG
Publication of FR2018070A1 publication Critical patent/FR2018070A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FR6931175A 1968-09-13 1969-09-12 Withdrawn FR2018070A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19681793422 DE1793422C3 (de) 1968-09-13 4,6-Dichlor-4,6-östradiene, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel, sowie rac-u.nat. 6-Chlor- lTbeta-acetoxy-ie-methyl-17 a-äthinyl-4,6-östradien-3-on als Ausgangsverbindungen

Publications (1)

Publication Number Publication Date
FR2018070A1 true FR2018070A1 (fr) 1970-05-29

Family

ID=5707698

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6931175A Withdrawn FR2018070A1 (fr) 1968-09-13 1969-09-12

Country Status (12)

Country Link
US (1) US3812166A (fr)
AT (1) AT289307B (fr)
BE (1) BE738803A (fr)
BR (1) BR6912323D0 (fr)
CH (1) CH536294A (fr)
DK (1) DK121656B (fr)
ES (1) ES370887A1 (fr)
FR (1) FR2018070A1 (fr)
GB (1) GB1287602A (fr)
IL (1) IL32973A (fr)
NL (1) NL164041C (fr)
SE (1) SE352080B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
EP2042181A1 (fr) * 2002-02-04 2009-04-01 ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. Utilisation des composés ayant la capacité de libérer le CO pour la préparation d'un médicament pour le traitement des maladies inflammatoires
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
US9163044B2 (en) 2011-04-19 2015-10-20 Alfama, Inc. Carbon monoxide releasing molecules and uses thereof
WO2013013179A1 (fr) 2011-07-21 2013-01-24 Alfama, Inc. Molécules libérant du ruthénium-monoxyde de carbone et utilisations de celles-ci

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1513740A (fr) * 1966-02-23 1968-02-16 Hoffmann La Roche Procédé pour la préparation de stéroïdes halogénés

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1513740A (fr) * 1966-02-23 1968-02-16 Hoffmann La Roche Procédé pour la préparation de stéroïdes halogénés

Also Published As

Publication number Publication date
DE1793422B2 (de) 1977-01-20
IL32973A0 (en) 1969-11-30
AT289307B (de) 1971-04-13
NL6913959A (fr) 1970-03-17
GB1287602A (en) 1972-09-06
US3812166A (en) 1974-05-21
NL164041B (nl) 1980-06-16
IL32973A (en) 1974-07-31
DE1793422A1 (de) 1971-07-01
DK121656B (da) 1971-11-15
BE738803A (fr) 1970-03-12
CH536294A (de) 1973-04-30
BR6912323D0 (pt) 1973-03-13
NL164041C (nl) 1980-11-17
ES370887A1 (es) 1971-07-01
SE352080B (fr) 1972-12-18

Similar Documents

Publication Publication Date Title
AU1946070A (fr)
AU428130B2 (fr)
AU2374870A (fr)
AU5184069A (fr)
AU6168869A (fr)
AU429879B2 (fr)
AU4811568A (fr)
AU421558B1 (fr)
AU3789668A (fr)
AU3224368A (fr)
AR203075Q (fr)
AU2580267A (fr)
NL6913959A (fr)
BE721800A (fr)
BE728513A (fr)
BE711484A (fr)
AU4558658A (fr)
BE728472A (fr)
BE727799A (fr)
BE728750A (fr)
BE727204A (fr)
AU4464266A (fr)
BE709496A (fr)
BE642636A (fr)
BE727941A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse